Neurimmune AG

Activities: Pharmaceutical

Trending Articles

  1. Data gathering developments As the use of RFID labelling spreads, the pharmaceutical industry is likely to see considerable benefits from this technology, says Richard Scott of SATO UK
  2. SRI International awarded US$19.8m National Cancer Institute contract for PREVENT Cancer programme Will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development
  3. Why use corrugated tubes in heat exchangers? There are a variety of tubular heat exchangers on the market, but for many applications corrugated tubes continue to be preferred over smooth ones. Matt Hale, International...
  4. Rousselot Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
  5. BD showcases latest drug delivery innovations at CPHI Milan 2024 Innovative drug delivery systems to meet the growing demands of pharma and biotech industries

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Research & Development

Astrazeneca to develop and commercialise Neurimmune antibody

NI006 is an investigational human monoclonal antibody specifically targeting misfolded transthyretin
Media

Biogen and Neurimmune announce option exercise for Aducanumab

The transaction will increase the profit potential of aducanumab for Biogen and provides near-term capital to Neurimmune
Subscribe now